Condition
Hypoactive Sexual Desire Disorder (HSDD)
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (1)
P 3 (2)
Trial Status
Completed4
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03619005Phase 3WithdrawnPrimary
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study
NCT01702818CompletedPrimary
Stress Hormones, Mood and Women's Sexual Desire (MODEST)
NCT03080298Phase 2CompletedPrimary
Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire
NCT02070029Not ApplicableCompletedPrimary
Acupuncture for Sexual Dysfunction
NCT00349791Phase 3CompletedPrimary
Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
Showing all 5 trials